BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
作者信息
Sheikh Aziz, Robertson Chris, Taylor Bob
机构信息
University of Edinburgh, Edinburgh, United Kingdom
University of Strathclyde, Glasgow, United Kingdom.
出版信息
N Engl J Med. 2021 Dec 2;385(23):2195-2197. doi: 10.1056/NEJMc2113864. Epub 2021 Oct 20.
Abstract
摘要
相似文献
1
BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
N Engl J Med. 2021 Dec 2;385(23):2195-2197. doi: 10.1056/NEJMc2113864. Epub 2021 Oct 20.
2
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
Lancet. 2022 Jan 1;399(10319):25-35. doi: 10.1016/S0140-6736(21)02754-9. Epub 2021 Dec 20.
3
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
N Engl J Med. 2022 Jan 27;386(4):340-350. doi: 10.1056/NEJMoa2115481. Epub 2022 Jan 12.
4
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.
BMC Med. 2023 Feb 28;21(1):78. doi: 10.1186/s12916-023-02795-w.
5
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
6
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
Lancet Respir Med. 2021 Dec;9(12):1439-1449. doi: 10.1016/S2213-2600(21)00380-5. Epub 2021 Sep 29.
7
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
EBioMedicine. 2022 Jan;75:103761. doi: 10.1016/j.ebiom.2021.103761. Epub 2021 Dec 17.
8
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
9
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.
Nat Med. 2021 Dec;27(12):2127-2135. doi: 10.1038/s41591-021-01548-7. Epub 2021 Oct 14.
10
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2091865. doi: 10.1080/21645515.2022.2091865. Epub 2022 Jul 11.
引用本文的文献
1
Immune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 Vaccine.
Infect Chemother. 2025 Jun;57(2):274-287. doi: 10.3947/ic.2024.0145. Epub 2025 Apr 16.
2
Advanced biopolymeric materials and nanosystems for RNA/DNA vaccines: a review.
Nanomedicine (Lond). 2024;19(24):2027-2043. doi: 10.1080/17435889.2024.2382077. Epub 2024 Aug 7.
3
Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy.
Vaccines (Basel). 2024 Apr 13;12(4):413. doi: 10.3390/vaccines12040413.
4
Lessons we learned during the past four challenging years in the COVID-19 era: pharmacotherapy, long COVID complications, and vaccine development.
Virol J. 2024 Apr 26;21(1):98. doi: 10.1186/s12985-024-02370-6.
5
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Viruses. 2024 Jan 29;16(2):203. doi: 10.3390/v16020203.
6
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.
Front Immunol. 2023 Dec 12;14:1264323. doi: 10.3389/fimmu.2023.1264323. eCollection 2023.
7
SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case-Control Study.
Vaccines (Basel). 2023 Nov 28;11(12):1779. doi: 10.3390/vaccines11121779.
8
A deterministic compartmental model for the transition between variants in the spread of Covid-19 in Italy.
PLoS One. 2023 Nov 14;18(11):e0293416. doi: 10.1371/journal.pone.0293416. eCollection 2023.
9
Clinical Severity of SARS-CoV-2 Variants during COVID-19 Vaccination: A Systematic Review and Meta-Analysis.
Viruses. 2023 Sep 26;15(10):1994. doi: 10.3390/v15101994.
10
Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city.
Nat Commun. 2023 Jun 15;14(1):3563. doi: 10.1038/s41467-023-39322-7.
Zotero 插件